Minoryx Therapeutics Revenue and Competitors

Mataró,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Minoryx Therapeutics's estimated annual revenue is currently $6.7M per year.(i)
  • Minoryx Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Minoryx Therapeutics has 43 Employees.(i)
  • Minoryx Therapeutics grew their employee count by 5% last year.

Minoryx Therapeutics's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Minoryx Therapeutics?

Minoryx is a clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company's lead program, leriglitazone (MIN-102), a novel, selective PPARγ agonist, is currently being evaluated in X-ALD and Friedreich's Ataxia. The company is backed by a syndicate of experienced investors and has support from a network of other organizations. Minoryx was founded in 2011, has operations in Spain and Belgium and has raised a total of €50M through Series A & B financing rounds.

keywords:N/A

N/A

Total Funding

43

Number of Employees

$6.7M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Minoryx Therapeutics News

2022-04-17 - Adrenoleukodystrophy Drugs Market Insights, Growth Analysis ...

List of Key Players Covered in the Report: Applied Genetic Technologies Corporation, MedDay SA, Bluebird bio, Inc., Minoryx Therapeutics S.L...

2022-04-17 - X-linked Adrenoleukodystrophy Pipeline Market Research ...

... have their X linked Adrenoleukodystrophy drug candidates in the most advanced stage, i.e. phase II/ III include, Minoryx Therapeutics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.1M12422%N/A
#2
$47.5M16042%N/A